Fig. 1From: Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemiaChanges in Hb (A), Hct (B), and NT-proBNP (C) levels during a 3-month follow-up. Data are presented as means ± SD. Hb hemoglobin, Hct hematocritBack to article page